ASHRAF MIKHAIL: Open Payments
NPI 1083690515 · JACKSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 37 payments from 11 companies in 2025. Trend: 2023 $838 · 2024 $792 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $157 |
| ABBVIE INC. | 13 | $139 |
| Supernus Pharmaceuticals, Inc. | 3 | $50 |
| Axsome Therapeutics, Inc. | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Alkermes, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Luye Pharma (USA) Ltd. | 1 | $16 |
Products named: CAPLYTA, VRAYLAR, Qelbree, Auvelity, AUSTEDO XR, ABILIFY ASIMTUFII, SPRAVATO, ARISTADA.
Industry payments across NC — which companies pay providers there.
